Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JPMA Health Policy Seminar
March 27, 2006
- Korosho Calls For Stable, Nationwide Supply of Generics at All Strengths
March 27, 2006
- Seminar
March 27, 2006
- Notification on Measures to Promote the Use of Generics Issued
March 27, 2006
- Seminar
March 27, 2006
- Towa, Sawai, and Nichi-iko Will Cooperate to Supply All Specifications
March 27, 2006
- New 3-year Regulatory Reform Plan Coming Soon
March 27, 2006
- Taiyo to Independently Supply All Specifications
March 27, 2006
- REGULATORY NEWS IN BRIEF
March 27, 2006
- JGPMA to Distribute "GE Drug Consultation Card" Free of Charge
March 27, 2006
- Notifications Issued to Explain New Medical Fees
March 27, 2006
- GSK to Begin Clinical Trial of Cervarix in Japan
March 27, 2006
- Rivalry Heats Up as Election Approaches: JMA
March 27, 2006
- Korosho Submits Proposal for "vaccine Industry Vision"
March 27, 2006
- Mr Kodama to Concentrate on JPA
March 27, 2006
- Aricept Improves Cognitive Function in Vascular Dementia: Eisai
March 27, 2006
- 200 Jobs Expected to Be Cut at Banyu by End of March
March 27, 2006
- Blopress Reduces Onset of Hypertension by 15.6%: Takeda
March 27, 2006
- SSP Extends Childcare-leave Period to 3 Years
March 27, 2006
- Crestor Reverses Plaque Build-up in Coronary Artery Disease
March 27, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…